Does HIV Exploit the Inflammatory Milieu of the Male Genital Tract for Successful Infection?

Rachel T Esra, Abraham J Olivier, Jo-Ann S Passmore, Heather B Jaspan, Rushil Harryparsad, Clive M Gray, Rachel T Esra, Abraham J Olivier, Jo-Ann S Passmore, Heather B Jaspan, Rushil Harryparsad, Clive M Gray

Abstract

In many parts of the World, medical male circumcision (MMC) is used as standard prevention of care against HIV infection. This is based on seminal reports made over 10 years ago that removal of the foreskin provides up to 60% protection against HIV infection in males and seems currently the best antiretroviral-free prevention strategy yet against the global epidemic. We explore the potential mechanisms by which MMC protects against HIV-1 acquisition and that one of the oldest, albeit re-invented, rituals of removing a foreskin underscores the exploitative nature of HIV on the anatomy and tissue of the uncircumcised penis. Furthermore, foreskin removal also reveals how males acquire HIV, and in reality, the underlying mechanisms of MMC are not known. We argue that the normal sequelae of inflammation in the male genital tract (MGT) for protection from sexually transmitted infections (STI)-induced pathology represents a perfect immune and microbial ecosystem for HIV acquisition. The accumulation of HIV-1 target cells in foreskin tissue and within the urethra in response to STIs, both during and after resolution of infection, suggests that acquisition of HIV-1, through sexual contact, makes use of the natural immune milieu of the MGT. Understanding immunity in the MGT, the movement of HIV-1 target cells to the urethra and foreskin tissue upon encounter with microbial signals would provide more insight into viral acquisition and lay the foundation for further prevention strategies in males that would be critical to curb the epidemic in all sexual partners at risk of infection. The global female-centric focus of HIV-1 transmission and acquisition research has tended to leave gaps in our knowledge of what determines HIV-1 acquisition in men and such understanding would provide a more balanced and complete view of viral acquisition.

Keywords: HIV-1; acquisition; exploitation; inflammation; medical male circumcision; risk factors; sexually transmitted infections.

Figures

Figure 1
Figure 1
Factors affecting HIV infection of the male genital tract. (A) The foreskin consists of a double layer of stratified epithelium that covers the glans/corona and meatus of a flaccid penis. (B) Circumcision results in the removal of the majority of the foreskin epithelium leaving a “dry” keratinized surface that is assumed to be resistant to HIV infection. Non-STI genital microbial populations have been shown to modulate genital inflammation through the antigen recognition, which may result in migration or activation of HIV target cells into the foreskin. Circumcision results in a removal of the moist sub-preputial space and decrease in anaerobic bacterial species, which are likely pro-inflammatory. (C) The foreskin is a stratified epithelium consisting of six epidermal layers namely stratum corneum (SC), stratum granulosum (SG), stratum spinosum (SS), and stratum basale (SB). HIV virions crosses the keratinized (light brown) epithelial border through micro abrasions that occur during sexual intercourse or through the formation of viral synapses between HIV-infected cells and epithelial cells (20). Langerhans’ Cells (LCs) reside within the epidermis where they are the first to encounter the virus (21). Activated LCs migrate into the lower dermal tissues, transferring the virus to resident dermal immune cells such as T cells, macrophages, and epithelial dendritic cells (DCs). Dendritic cells act as professional antigen presenting cells, phagocytosing virions, and migrating to the draining lymph nodes where they present HIV antigens to immature T cells and B cells (22). Intact virus can be trafficked into the lymph nodes by DCs and transferred to CD4+ T cells (23) where the virus replicates and is disseminated throughout the body (24). Asymptomatic STIs do not present clinically but inflammation still occurs on a cellular level. The release of pro-inflammatory cytokines by keratinocytes and dermal immune cells in response to an STI would result in recruitment and activation immune cells to the site of infection. This inflammatory environment would result in an accumulation of HIV target cells and therefore increase the efficiency of viral transmission in the case of an HIV infection.

References

    1. Unaids. UNAIDS: The Gap Report 26. Geneva: Joint United Nations Programme on HIV/AIDS; (2014).
    1. Kelly RJ, Gray RH, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, et al. Age differences in sexual partners and risk of HIV-1 infection in rural Uganda. J Acquir Immune Defic Syndr (2003) 32:446–51.10.1097/00126334-200304010-00016
    1. Langen TT. Gender power imbalance on women’s capacity to negotiate self-protection against HIV/AIDS in Botswana and South Africa. Afr Health Sci (2005) 5:188–97.
    1. UNAIDS. Global AIDS response progress reporting 2014: Construction of Core Indicators for Monitoring the 2011 UN Political Declaration on HIV/AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; (2014).
    1. Beyrer C, Baral SD, Van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet (2012) 380:367–77.10.1016/S0140-6736(12)60821-6
    1. Abara WE, Garba I. HIV epidemic and human rights among men who have sex with in sub-Saharan Africa: implications for HIV prevention, care, and surveillance. Glob Public Health (2015) 1692:1–14.10.1080/17441692.2015.1094107
    1. van Harmelen J, Wood R, Lambrick M, Rybicki EP, Williamson AL, Williamson C. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. AIDS (1997) 11:81–7.10.1097/00002030-199701000-00012
    1. Middelkoop K, Rademeyer C, Brown BB, Cashmore TJ, Marais JC, Scheibe AP, et al. Epidemiology of HIV-1 subtypes among men who have sex with men in Cape Town, South Africa. J Acquir Immune Defic Syndr (2014) 65:473.10.1097/QAI.0000000000000067
    1. Ndiaye HD, Toure-Kane C, Vidal N, Niama FR, Niang-Diallo PA, Dièye T, et al. Surprisingly high prevalence of subtype C and specific HIV-1 subtype/CRF distribution in men having sex with men in Senegal. J Acquir Immune Defic Syndr (2009) 52:249–52.10.1097/QAI.0b013e3181af70a4
    1. Tovanabutra S, Sanders EJ, Graham SM, Mwangome M, Peshu N, McClelland RS, et al. Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya. AIDS Res Hum Retroviruses (2010) 26:123–31.10.1089/aid.2009.0115
    1. Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk. AIDS (2014) 28:1509–19.10.1097/QAD.0000000000000298
    1. Hughes JP, Baeten JM, Lingappa JR, Magaret AS, Wald A, De Bruyn G, et al. Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis (2012) 205:358–65.10.1093/infdis/jir747
    1. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med (2005) 2:e298.10.1371/journal.pmed.0020298
    1. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Eur Urol (2007) 52:605–6.10.1016/j.eururo.2007.04.090
    1. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 369:657–66.10.1016/S0140-6736(07)60313-4
    1. Nguyen PV, Kafka JK, Ferreira VH, Roth K, Kaushic C. Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection. Cell Mol Immunol (2014) 11:410–27.10.1038/cmi.2014.41
    1. Taves DR. The intromission function of the foreskin. Med Hypotheses (2002) 59:180–2.10.1016/S0306-9877(02)00250-5
    1. McCoombe SG, Short RV. Potential HIV-1 target cells in the human penis. AIDS (2006) 20:1491–5.10.1097/01.aids.0000237364.11123.98
    1. Schacker TW, Brenchley JM, Gregory J, Reilly C, Pambuccian SE, Taylor J, et al. Lymphatic tissue fibrosis is associated with reduced numbers of naïve CD4 + T cells in human immunodeficiency virus type 1 infection. Clin Vaccine Immunol (2006) 13:556–60.10.1128/CVI.13.5.556-560.2006
    1. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med (1997) 3:42–7.10.1038/nm0197-42
    1. De Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MA, de Gruijl T, et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med (2007) 13:367–71.10.1038/nm1541
    1. Wu L. Biology of HIV mucosal transmission. Curr Opin HIV AIDS (2008) 3:534–40.10.1097/COH.0b013e32830634c6
    1. Wu L, KewalRamani VN. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol (2006) 6:859–68.10.1038/nri1960
    1. Shattock RJ, Moore JP. Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol (2003) 1:25–34.10.1038/nrmicro729
    1. Anderson D, Politch JA, Pudney J. HIV infection and immune defense of the penis. Am J Reprod Immunol (2011) 65:220–9.10.1111/j.1600-0897.2010.00941.x
    1. Jayathunge PHM, McBride WJH, Maclaren D, Kaldor J, Vallely A, Turville S. Male circumcision and HIV transmission; what do we know? Open AIDS J (2014) 8:31–44.10.2174/1874613601408010031
    1. Fahrbach KM, Barry SM, Anderson MR, Hope TJ. Enhanced cellular responses and environmental sampling within inner foreskin explants: implications for the foreskin’s role in HIV transmission. Mucosal Immunol (2010) 3:410–8.10.1038/mi.2010.18
    1. Zhou Z, De Longchamps NB, Schmitt A, Zerbib M, Ganor Y, Bomsel M. HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5/RANTES that recruits T cells and fuels conjugate formation with Langerhans cells. PLoS Pathog (2011) 7:e1002100.10.1371/journal.ppat.1002100
    1. Padian NS, McLoy SI, Balkus JE, Wasserheit NJ. Weighing the gold in the gold standard: challenges in HIV prevention research. Changes (2012) 24:621–35.10.1097/QAD.0b013e328337798a
    1. Hirbod T, Bailey RC, Agot K, Moses S, Ndinya-achola J, Murugu R, et al. Abundant expression of HIV target cells and C-type lectin receptors in the foreskin tissue of young Kenyan men. Am J Pathol (2010) 176:2798–805.10.2353/ajpath.2010.090926
    1. Ganor Y, Zhou Z, Tudor D, Schmitt A, Vacher-Lavenu M-C, Gibault L, et al. Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunol (2010) 3:506–22.10.1038/mi.2010.32
    1. Prodger JL, Gray R, Kigozi G, Nalugoda F, Galiwango R, Hirbod T, et al. Foreskin T cell subsets differ substantially from blood with respect to HIV co-receptor expression, inflammatory profile and memory status. Mucosal Immunol (2012) 5:121–8.10.1038/mi.2011.56
    1. Lemos MP, Lama JR, Karuna ST, Fong Y, Montano SM, Ganoza C, et al. The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4 + CCR5 + cells and has features of an inflamed epidermal barrier. PLoS One (2014) 9:e108954.10.1371/journal.pone.0108954
    1. Ross HM, Romrell LJKG. Histology, a Text an Atlas. 3rd ed Baltimore: Williams & Wilkins; (1995).
    1. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol (2013) 31:1146.10.1146/annurev-immunol-020711-074950
    1. Hladik F, McElrath MJ. Setting the stage – HIV host invasion. Nat Rev Immunol (2008) 8:447–57.10.1038/nri2302
    1. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell (2000) 100:587–97.10.1016/S0092-8674(00)80694-7
    1. Baxter AE, Russell RA, Duncan CJ, Moore MD, Willberg CB, Pablos JL, et al. Macrophage infection via selective capture of HIV-1-infected CD4+ T cells. Cell Host Microbe (2014) 16:711–21.10.1016/j.chom.2014.10.010
    1. Anderson DJ, Pudney J. Human male genital tract immunity and experimental models. Mucosal Immunol (2005) 2:1647–59.10.1016/B978-012491543-5/50100-5
    1. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun (2004) 72:1843–55.10.1128/IAI.72.4.1843-1855.2004
    1. Edwards JL, Apicella MA. The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women the molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin Microbiol Rev (2004) 17:965–81.10.1128/CMR.17.4.965-981.2004
    1. McClure CP, Tighe PJ, Robins RA, Bansal D, Bowman CA, Kingston M, et al. HIV coreceptor and chemokine ligand gene expression in the male urethra and female cervix. AIDS (2005) 19:1257–65.10.1097/01.aids.0000180096.50393.96
    1. Fischetti L, Barry SM, Hope TJ, Shattock RJ. HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS (2009) 23:319–28.10.1097/QAD.0b013e328321b778
    1. Dinh MH, Anderson MR, McRaven MD, Cianci GC, McCoombe SG, Kelley ZL, et al. Visualization of HIV-1 interactions with penile and foreskin epithelia: clues for female-to-male HIV transmission. PLoS Pathog (2015) 11:e1004729.10.1371/journal.ppat.1004729
    1. Ganor Y, Zhou Z, Bodo J, Tudor D, Leibowitch J, Mathez D, et al. The adult penile urethra is a novel entry site for HIV-1 that preferentially targets resident urethral macrophages. Mucosal Immunol (2013) 6:776–86.10.1038/mi.2012.116
    1. Tobian AAR, Kigozi DS, Quinn TC, Kigozi G, Gravitt PE, Laeyendecker O, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med (2009) 360:1298–309.10.1056/NEJMoa0802556
    1. Sobngwi-Tambekou J, Taljaard D, Lissouba P, Zarca K, Puren A, Lagarde E, et al. Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis (2009) 199:958–64.10.1086/597208
    1. Mehta SD, Moss S, Parker CB, Agot K, Maclean I, Bailey RC. Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection. AIDS (2012) 29:997–1003.10.1097/QAD.0b013e328352d116
    1. Weiss HA, Thomas SL, Munabi SK, Hayes RJ. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect (2006) 82:101–9.10.1136/sti.2005.017442
    1. O’Farrell N, Morison L, Chung C-K. Low prevalence of penile wetness among male sexually transmitted infection clinic attendees in London. Sex Transm Dis (2007) 34:408–9.10.1097/01.olq.0000240294.79426.a3
    1. O’Farrell N, Morison L, Moodley P, Pillay K, Vanmali T, Quigley M, et al. Association between HIV and subpreputial penile wetness in uncircumcised men in South Africa. J Acquir Immune Defic Syndr (2006) 43:69–77.10.1097/01.qai.0000225014.61192.98
    1. Nsanze H, Fast MV, D’Costa LJ, Tukei P, Curran J, Ronald A. Genital ulcers in Kenya. Clinical and laboratory study. Br J Vener Dis (1981) 57:378–81.
    1. Mehta SD, Moses S, Agot K, Parker C, Ndinya-achola JO, Maclean I, et al. Adult male circumcision does not reduce risk of incident Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: results from a randomized controlled trial in Kenya. J Infect Dis (2009) 200:370–8.10.1086/600074
    1. Drain PK, Halperin DT, Hughes JP, Klausner JD, Bailey RC. Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries. BMC Infect Dis (2006) 6:172.10.1186/1471-2334-6-85
    1. Castellsagué X, Bosch F, Muñoz N, Meijer CJ, Shah KV, de Sanjose S. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med (2002) 346:1105–12.10.1056/NEJMoa011688
    1. Kjaer SK, de Villiers EM, Dahl C, Engholm G, Bock JE, Vestergaard BF, et al. Case-control study of risk factors for cervical neoplasia in Denmark. I: role of the “male factor” in women with one lifetime sexual partner. Int J Cancer (1991) 48:39–44.10.1002/ijc.2910480108
    1. Brinton LA, Reeves WC, Brenes MM, Herrero R, Gaitan E, Tenorio F, et al. The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer (1989) 44:199–203.10.1002/ijc.2910440202
    1. Dickson NP, Ryding J, Van Roode T, Paul C, Herbison P, Dillner J, et al. Male circumcision and serologically determined human papillomavirus infection in a birth cohort. Cancer Epidemiol Biomarkers Prev (2009) 18:177–83.10.1158/1055-9965.EPI-08-0353
    1. Wawer MJ, Tobian AA, Kigozi G, Kong X, Gravitt PE, Serwadda D, et al. Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet (2011) 377:209–18.10.1016/S0140-6736(10)61967-8
    1. Zhu YP, Jia ZW, Dai B, Ye DW, Kong YY, Chang K, et al. Relationship between circumcision and human papillomavirus infection: a systematic review and meta-analysis. Asian J Androl (2016) 18:1–7.10.4103/1008-682X.175092
    1. Hernandez BY, Wilkens LR, Zhu X, McDuffie K, Thompson P, Shvetsov YB, et al. Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis (2008) 197:787–94.10.1086/528379
    1. Hernandez BY, Shvetsov YB, Goodman MT, Wilkens LR, Thomson P, Zhu X, et al. Reduced clearance of penile human papillomavirus infection in uncircumcised men. J Infect Dis (2010) 201:1340–3.10.1086/651607
    1. Donoval BA, Landay AL, Moses S, Agot K, Ndinya-Achola JO, Nyagaya EA, et al. HIV-1 target cells in foreskin of African men with varying histories of sexually transmitted infections. Am J Clin Pathol (2006) 125:386–91.10.1309/JVHQVDJDYKM58EPH
    1. Sbazo R, Short RV. How does male circumcision protect against HIV infection? BMJ (2000) 320:1592–4.10.1136/bmj.320.7249.1592
    1. Stillwaggon E, Sawers L. Rush to judgment: the STI-treatment trials and HIV in sub-Saharan Africa. J Int AIDS Soc (2015) 18:19844.10.7448/IAS.18.1.19844
    1. Barnabas RV, Webb EL, Weiss HA, Wasserheit JN. The role of coinfections in HIV epidemic trajectory and positive prevention. AIDS (2011) 25:1559–73.10.1097/QAD.0b013e3283491e3e
    1. Sexton J, Garnett G, Røttingen J-A. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis (2005) 32:351–7.10.1097/01.olq.0000154504.54686.d1
    1. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet (1995) 346(8974):530–6.10.1016/S0140-6736(95)91380-7
    1. Gray RH, Wawer MJ. Reassessing the hypothesis on STI control for HIV prevention. Lancet (2008) 371:2064–5.10.1016/S0140-6736(08)60896-X
    1. Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med (2009) 15:886–92.10.1038/nm.2006
    1. Prodger JL, Gray R, Kigozi G, Nalugoda F, Nehemiah K, Kakanga M, et al. Impact of asymptomatic herpes simplex virus-2 infection on T cell function in the foreskin of men from Rakai, Uganda. AIDS (2014) 26:1319–22.10.1097/QAD.0b013e328354675c
    1. Johnson KE, Redd AD, Quinn TC, Collinson-streng AN, Cornish T, Kong X, et al. Effects of HIV-1 and herpes simplex virus type 2 infection on lymphocyte and dendritic cell density in adult foreskins from Rakai, Uganda. J Infect Dis (2011) 203:602–9.10.1093/infdis/jiq091
    1. Rohl M, Tjernlund A, Mehta SD, Pettersson P, Bailey RC, Broliden K. Comparable mRNA expression of inflammatory markers but lower claudin-1 mRNA levels in foreskin tissue of HSV-2 seropositive versus seronegative asymptomatic Kenyan young men. BMJ Open (2015) 5:e006627.10.1136/bmjopen-2014-006627
    1. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog (2010) 6:e1000852.10.1371/journal.ppat.1000852
    1. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature (2011) 474:327–36.10.1038/nature10213
    1. Young VB. The intestinal microbiota in health and disease. Curr Opin Gastroenterol (2012) 28:63–9.10.1097/MOG.0b013e32834d61e9
    1. Weyrich LS, Dixit S, Farrer AG, Cooper AJ, Cooper AJ. The skin microbiome: associations between altered microbial communities and disease. Australas J Dermatol (2015) 56(4):268–74.10.1111/ajd.12253
    1. Skabytska Y, Kaesler S, Volz T, Biedermann T. How the innate immune system trains immunity: lessons from studying atopic dermatitis and cutaneous bacteria. J Dtsch Dermatol Ges (2016) 14:153–6.10.1111/ddg.12843
    1. Barnard E, Li H. Shaping of cutaneous function by encounters with commensals. J Physiol (2016) 594:1–17.10.1113/JP271638
    1. Liu CM, Hungate BA, Tobian AAR, Serwadda D, Ravel J, Lester R, et al. Male circumcision significantly reduces prevalence and load of genital anaerobic bacteria. MBio (2013) 4:1–9.10.1128/mBio.00076-13
    1. Price LB, Liu CM, Johnson KE, Aziz M, Lau MK, Bowers J, et al. The effects of circumcision on the penis microbiome. PLoS One (2010) 5:e8422.10.1371/journal.pone.0008422
    1. De Jong MA, Geijtenbeek TB. Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players. J Intern Med (2009) 265:18–28.10.1111/j.1365-2796.2008.02046.x
    1. Ogawa Y, Kawamura T, Kimura T, Ito M, Blauvelt A, Shimada S. Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via toll-like receptor activation. Blood (2009) 113:5157–67.10.1182/blood-2008-10-185728
    1. Nelson DE, Dong Q, van der Pol B, Toh E, Fan B, Katz BP, et al. Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS One (2012) 7:e36298.10.1371/journal.pone.0036298
    1. O’Farrell N, Chung CK, Weiss HA. Foreskin length in uncircumcised men is associated with subpreputial wetness. Int J STD AIDS (2008) 19:821–3.10.1258/ijsa.2008.008106
    1. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (2008) 22:1493–501.10.1097/QAD.0b013e3283021a37
    1. Myer L, Denny L, Telerant R, de Souza M, Wright TC, Jr, Kuhn L. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis (2005) 192:1372–80.10.1086/462427
    1. Gray RH, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, Watya S, et al. The effects of male circumcision on female partners’ genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol (2009) 200:42.e1–7.10.1016/j.ajog.2008.07.069
    1. Liu CM, Hungate BA, Tobian AAR, Ravel J, Prodger JL, Serwadda D, et al. Penile microbiota and female partner bacterial vaginosis in Rakai, Uganda. MBio (2015) 6:17–20.10.1128/mBio.00589-15
    1. Lutz AR. Screening for asymptomatic extragenital gonorrhea and chlamydia in men who have sex with men: significance, recommendations, and options for overcoming barriers to testing. LGBT Health (2015) 2:27–34.10.1089/lgbt.2014.0056
    1. Rebe K, Lewis D, Myer L, de Swardt G, Struthers H, Kamkuemah M, et al. A cross sectional analysis of gonococcal and chlamydial infections among men-who-have-sex-with-men in Cape Town, South Africa. PLoS One (2015) 10:e0138315.10.1371/journal.pone.0138315
    1. Irwin K. Observations from the CDC the silent epidemic of Chlamydia trachomatis: the urgent need for detection and treatment in women the problem: a highly prevalent asymptomatic infection linked. J Womens Health Gender-Based Med (2009) 9:339–43.
    1. Ficarra M, Ibana JS, Poretta C, Ma L, Myers L, Taylor SN, et al. A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection. Am J Reprod Immunol (2008) 60:415–25.10.1111/j.1600-0897.2008.00639.x
    1. Buckner LR, Amedee AM, Albritton HL, Kozlowski PA, Lacour N, McGowin CL, et al. Chlamydia trachomatis infection of endocervical epithelial cells enhances early HIV transmission events. PLoS One (2016) 11:e0146663.10.1371/journal.pone.0146663
    1. Anderson D, Politch JA, Pudney J. HIV Infection of the penis. Am J Reprod Immunol (2010) 65:220–9.10.1111/j.1600-0897.2010.00941.x
    1. World Health Organisation, Joint United Nations Programme on HIV and AIDS. WHO and UNAIDS Announce Recommendations from Expert Consultation on Male Circumcision for HIV Prevention. Vol. 1 Geneva: World Health Organisation; (2007).
    1. WHO. WHO Progress Brief – Voluntary Medical Male Circumcision for HIV Prevention in Priority Countries of East and Southern Africa. Geneva: World Health Organisation; (2014).
    1. Weiss HA, Halperin D, Hayes RJ, Schmid G, Hankins CA. Male circumcision for HIV prevention: from evidence to action? AIDS (2008) 22:567–74.10.1097/QAD.0b013e3282f3f406
    1. Muula AS, Prozesky HW, Mataya RH, Ikechebelu JI. Prevalence of complications of male circumcision in anglophone Africa: a systematic review. BMC Urol (2007) 7:4.10.1186/1471-2490-7-4
    1. Wilcken A, Keil T, Dick B. Traditional male circumcision in eastern and southern Africa: a systematic review of prevalence and complications. Bull World Health Organ (2010) 88:907–14.10.2471/BLT.09.072975
    1. Bedimo AL, Bennett M, Kissinger P, Clark RA. Understanding barriers to condom usage among HIV-infected African American women. J Assoc Nurses AIDS Care (1998) 9:48–58.10.1016/S1055-3290(98)80019-8
    1. Ahmed S, Lutalo T, Wawer MJ, Serwadda D, Sewankambo NK, Nalugoda F, et al. HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda. AIDS (2001) 15:2171–9.10.1097/00002030-200111090-00013
    1. Weller S, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev (2002) 1:1–22.10.1002/14651858.CD003255

Source: PubMed

3
Sottoscrivi